Skip to text Skip to main menu

CELLPURICS

COMPANY

About

CELLPURICS

Hello,
I am Ji-Woong Shin, the CEO of CellPurics.

Since our founding in 2021, we have been at the forefront of developing advanced medicines for pets, driven by our commitment to enhancing the health and well-being of pets through innovative research and development.

We are actively engaged in creating stem cell therapies and anti-cancer immune cell therapies for pets,
leveraging our specialized expertise in stem cell and immune cell culture technologies.
In addition, we are committed to enhancing the early detection and treatment of pet diseases through the application of molecular diagnostics and immunodiagnostics.

Our research capabilities and technological advancements not only support the health of pets but also humans.
As a dedicated research and development service organization, we evaluate the efficacy of drug candidates through the insights of life science experts and the application of cutting-edge analytical technologies, thereby facilitating innovative drug development.

We place the utmost importance on our customer relationships and are committed to delivering exceptional service.
Our success is intrinsically linked to the trust and satisfaction of our clients, and we pledge to pursue excellence in every endeavor.

As we move forward, we will continue our commitment to innovation and excellence, with the aim of providing the highest quality healthcare solutions for pets and enhancing the efficiency of drug discovery to ultimately improve the health of both pets and humans.

Thank you.

From CellPurics CEO